SCHEMBL6979608

SCHEMBL6979608

CCOC(=O)n1cc(-n2c(-c3cn(CCCOC(C)=O)c4ccccc34)c(C(N)=O)[nH]c2=O)c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 6/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
KMT2A Q03164 2/20 0.35
PIM1 P11309 1/20 0.35
FLT3 P36888 1/20 0.35
GSK3B P49841 1/20 0.35
CREBBP Q92793 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
CNR1 P21554 3/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981421 0.88 ALDH1A1 (0.42) CAMK2DSMN1; SMN2KMT2APIM1ALDH1A1
SCHEMBL6981894 0.87 MAPT (0.37) CAMK2DSMN1; SMN2KMT2APIM1FLT3
SCHEMBL7812900 0.83 SMN1; SMN2 (0.36) CAMK2DSMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL6980034 0.76 CCNT1 (0.48) CAMK2DSMN1; SMN2KMT2APIM1CREBBP
SCHEMBL6978208 0.76 CNR1 (0.40) ALDH1A1CNR1CA12CA1CA2
SCHEMBL6981135 0.75 ALDH1A1 (0.40) CAMK2DSMN1; SMN2KMT2AGSK3BALDH1A1
SCHEMBL6985899 0.75 MAPT (0.40) SMN1; SMN2KMT2AALDH1A1MEN1NPC1
SCHEMBL7005879 0.75 PIM1 (0.48) CAMK2DSMN1; SMN2KMT2APIM1GSK3B
Acetic Acid SCHEMBL7011660 0.75 CAMK2D (0.46) CAMK2DSMN1; SMN2KMT2APIM1GSK3B
SCHEMBL7011646 0.74 ALDH1A1 (0.39) CAMK2DSMN1; SMN2KMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1095039-B1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2003-08-27 EP disclosed
US-6346625-B1 ENZYME INHIBITORS FOR PROTEIN KINASES ASTRAZENECA AB (SE) 2002-02-12 US disclosed
EP-1095039-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS AstraZeneca AB (SE) 2001-05-02 EP disclosed
WO-2000002877-A2 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed